Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice
Journal of the American Heart Association · 12.11.2026
DOI: 10.1161/jaha.126.049332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, online erschienen am 12.11.2026. Verfasst von William W Wroe und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Vivian L. Smith Department of Neurosurgery, McGovern Medical School The University of Texas Health Science Center at Houston Houston TX USA. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Background
Microthrombi formation in the cerebral microvasculature has been demonstrated in animal models of subarachnoid hemorrhage (SAH) as well as autopsy studies of patients with aneurysmal SAH, and microthrombi are thought to contribute to delayed cerebral ischemia and poor neurological outcomes. Our hypothesis was that treatment with tirofiban, an antiplatelet drug that inhibits glycoprotein IIb/IIIa, would reduce microthrombi formation and the subsequent sequalae, delayed cerebral ischemia, in aged mice.
Methods
SAH was induced via endovascular perforation in male mice, and blood injection in female mice, followed by treatment with either tirofiban or saline. Mice underwent daily neurological assessment for 6 days and then were euthanized. Magnetic resonance imaging scans were obtained on days 2, 4, and 6 after SAH to identify infarcted tissue. Magnetic resonance imaging perfusion and laser speckle contrast imaging were performed to evaluate cerebral perfusion. Postmortem microthrombi formation in the cerebral microvascular was quantified.
Results
Tirofiban treatment in male mice, compared with saline, led to reduced microthrombi formation, and prevented delayed infarct growth and neurological decline. In female mice, significant neurobehavioral improvements were observed, which corresponded with fewer brain microthrombi. No female mice had infarction, nor was delayed cerebral ischemia detected in any female mouse.
Conclusions
After SAH in mice, treatment with tirofiban reduces both cerebral microthrombi formation and delayed infarct growth leading to a subsequent improvement in neurological outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Vivian L. Smith Department of Neurosurgery, McGovern Medical School The University of Texas Health Science Center at Houston Houston TX USA.
- Department of Diagnostic and Interventional Imaging, McGovern Medical School The University of Texas McGovern Medical School at Houston Houston TX USA.
- Department of Biosciences Rice University Houston Texas USA.
- Kinesiology Department Rice University Houston Texas USA.
ORCID-Profile: William W Wroe, Ari Dienel, Kiara Torres, Peeyush Thankamani Pandit, Richard Cook, Shuning Huang, Samitha Nemirajaiah, Spiros L Blackburn, Devin W McBride
Zitieren
APA
Wroe, W. W., Hong, S. H., Dienel, A., Torres, K., Potluri, S., Pandit, P. T., Cook, R., Huang, S., Kavula, S., Kaur, H., Nemirajaiah, S., Blackburn, S. L., & McBride, D. W. (2026). Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice. Journal of the American Heart Association. https://doi.org/10.1161/jaha.126.049332
Vancouver
Wroe WW, Hong SH, Dienel A, Torres K, Potluri S, Pandit PT, et al. Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice. Journal of the American Heart Association. 2026. doi:10.1161/jaha.126.049332
BibTeX
@article{Wroe2026,
author = {Wroe, William W and Hong, Sung-Ha and Dienel, Ari and Torres, Kiara and Potluri, Srilatha and Pandit, Peeyush Thankamani and Cook, Richard and Huang, Shuning and Kavula, Sanjana and Kaur, Harveen and Nemirajaiah, Samitha and Blackburn, Spiros L and McBride, Devin W},
title = {Tirofiban Prevents Delayed Cerebral Ischemia After Subarachnoid Hemorrhage in Aged Mice},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.126.049332}
}
EUVIMED